GeoVax Labs Inc (GOVX)

[poods]

Agree that's the right strategy. This company has been slowly building assets using very good science. This was recently confirmed with the apparent antibody dependent enhancement of dengue fever associated with the Sanofi vaccine in patients who did not have prior dengue exposure. Geovax approach to the sister Zika virus seems to circumvent this problem. This shows real prescience by Geovax scientists. Their approach to HIV has been similarly stepwise and methodical. This company is way undervalued IMO. They have been able to come remarkably far on grants, avoiding dilution, and the next step will be a partnership to take vaccines with very good prospects into final efficacy trials.